Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Browse by Journal Title

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type
Jump to: 2016 | 2015 | 2007 | 2006 | 2005 | 2003 | 2001 | 1999 | 1998 | 1996 | 1995 | 1994 | 1993

2016

BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features.
Neuendorff, N.R. and Burmeister, T. and Doerken, B. and Westermann, J.
Annals of Hematology 95 (8): 1211-1221. August 2016

2015

Flow cytometric maturity score as a novel prognostic parameter in patients with acute myeloid leukemia.
Schneider, T. and Flörcken, A. and Singh, A. and Türkmen, S. and Burmeister, T. and Anagnostopoulos, I. and Pezzutto, A. and Dörken, B. and Westermann, J.
Annals of Hematology 94 (8): 1337-1345. August 2015

Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis.
Lerch, K. and Meyer, A.H. and Stroux, A. and Hirt, C. and Keller, U. and Viardot, A. and Marks, R. and Schreiber, S. and Pezzutto, A. and Scholz, C.W.
Annals of Hematology 94 (6): 981-988. June 2015

2007

Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution.
Choquet, S. and Oertel, S. and Leblond, V. and Riess, H. and Varoqueaux, N. and Doerken, B. and Trappe, R.
Annals of Hematology 86 (8): 599-607. August 2007

2006

Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
Oertel, S. and Trappe, R.U. and Zeidler, K. and Babel, N. and Reinke, P. and Hummel, M. and Jonas, S. and Papp-Vary, M. and Subklewe, M. and Doerken, B. and Riess, H. and Gaertner, B.
Annals of Hematology 85 : 478-484. July 2006

Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab-monitoring of antiphospholipid and anti-GP antibodies: a case report.
Trappe, R. and Loew, A. and Thuss-Patience, P. and Doerken, B. and Riess, H.
Annals of Hematology 85 : 134-135. February 2006

2005

Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis.
Scholz, C. and Nimmrich, I. and Burger, M. and Becker, E. and Doerken, B. and Ludwig, W.D. and Maier, S.
Annals of Hematology 84 : 236-244. 1 January 2005

2003

Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy - results of a randomized trial.
Glossmann, J.P. and Engert, A. and Wassmer, G. and Flechtner, H. and Ko, Y. and Rudolph, C. and Metzner, B. and Doerken, B. and Wiedenmann, S. and Diehl, V. and Josting, A.
Annals of Hematology 82 (8): 469-475. 1 August 2003

Preexistence and evolution of imatinib mesylate-resistant clones in chronic myelogenous leukemia detected by a PNA-based PCR clamping technique.
Kreuzer, K.A. and Le Coutre, P. and Landt, O. and Na, I.K. and Schwarz, M. and Schultheis, K. and Hochhaus, A. and Doerken, B.
Annals of Hematology 82 (5): 284-289. May 2003

2001

Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
Grenzebach, J. and Schrappe, M. and Ludwig, W.D. and Parwaresch, R. and Zimmermann, M. and Gadner, H. and Riehm, H. and Reiter, A.
Annals of Hematology 80 Suppl 3 : B73-B76. 1 January 2001

1999

Intracellular expression of CD61 precedes surface expression.
Kaefer, G. and Willer, A. and Ludwig, W.D. and Kraemer, A. and Hehlmann, R. and Hastka, J.
Annals of Hematology 78 : 472-474. 1 October 1999

1998

Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia.
Kern, W. and Aul, C. and Maschmeyer, G. and Kuse, R. and Kerkhoff, A. and Grote-Metke, A. and Eimermacher, H. and Kubica, U. and Woermann, B. and Buechner, T. and Hiddemann, W.
Annals of Hematology 77 : 115-122. 1 September 1998

Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia.
Ratei, R. and Sperling, C. and Karawajew, L. and Schott, G. and Schrappe, M. and Harbott, J. and Riehm, H. and Ludwig, W.D.
Annals of Hematology 77 : 107-114. 1 September 1998

Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
Behre, G. and Link, H. and Maschmeyer, G. and Meyer, P. and Paaz, U. and Wilhelm, M. and Hiddemann, W.
Annals of Hematology 76 : 73-80. 1 February 1998

1996

New approaches in plasminogen activator therapy.
Bode, C. and Gulba, D. and Huber, K. and Runge, M.S.
Annals of Hematology 73 : 1-7. 1 January 1996

Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose intensive chemotherapy.
Bokemeyer, C. and Kuczyk, M.A. and Koehne, H. and Einsele, H. and Kynast, B. and Schmoll, H.J.
Annals of Hematology 72 (1): 1-9. 1 January 1996

Thrombolytic agents - an overview.
Gulba, D.C. and Bode, C. and Runge, M.S. and Huber, K.
Annals of Hematology 73 Suppl. 1 : S9-27. 1 January 1996

Thrombolytic therapy in acute myocardial infarction-update 1996.
Huber, K. and Runge, M.S. and Bode, C. and Gulba, D.C.
Annals of Hematology 73 : 29-38. 1 January 1996

Restenosis following percutaneous revascularization - the potential role of thrombin and the thrombin receptor.
Stouffer, G.A. and Schmedtje, J.F. and Gulba, D. and Huber, K. and Bode, C. and Aaron, J. and Runge, M.S.
Annals of Hematology 73 Suppl. 1 : S39-S41. 1 January 1996

1995

Aerosol amphotericin b inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients.
Behre, G.F. and Schwartz, S. and Lenz, K. and Ludwig, W.D. and Schilling, E. and Heinemann, V. and Link, H. and Boenisch, O. and Treder, W. and Siegert, W. and Wandt, H. and Trittin, A. and Hiddemann, W. and Beyer, J.
Annals of Hematology 71 (6): 287-291. 1 January 1995

1994

Thrombolysis in thromobembolic disease.
Gulba, D. and Dechend, R.
Annals of Hematology 69 Suppl. : S41-S57. 1 January 1994

Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy.
Link, H. and Maschmeyer, G. and Meyer, P. and Hiddemann, W. and Stille, W. and Helmerking, M. and Adam, D.
Annals of Hematology 69 : 231-243. 1 January 1994

Persistence of bcr-abl mRNA-expressing cells in long-term cultures established from chronic myeloid leukemic bone marrow or blood.
Pasternak, G. and Pasternak, L.
Annals of Hematology 68 : 9-14. 1 January 1994

1993

Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia--initial results.
Ganser, A. and Heil, G. and Kolbe, K. and Maschmeyer, G. and Fischer, J.T. and Bergmann, L. and Mitrou, P.S. and Heit, W. and Heimpel, H. and Huber, C. and Hoelzer, D.
Annals of Hematology 66 : 123-125. 1 January 1993

Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. The AML Cooperative Group.
Haferlach, T. and Gassmann, W. and Loeffler, H. and Juergensen, C. and Noak, J. and Ludwig, W.D. and Thiel, E. and Haase, D. and Fonatsch, C. and Becher, R. and Schlegelberger, B. and Nowrousian, M.R. and Lengfelder, E. and Eimermacher, H. and Weh, H.J. and Braumann, D. and Maschmeyer, G. and Koch, P. and Heinecke, A. and Sauerland, M.C. and Buechner, T.
Annals of Hematology 66 : 165-170. 1 January 1993

This list was generated on Tue Dec 18 02:23:24 2018 CET.
Open Access
MDC Library